Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNYSE
TAK
Takeda Pharmaceutical Company Limited
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for TAK
Full TAK profile on Quantisnow Follow TAK and get a push notification the moment its next story breaks.